Aberrant cell migration contributes to defective airway epithelial repair in childhood wheeze
Open Access
- 9 April 2020
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
Abstract
Abnormal wound repair has been observed in the airway epithelium of patients with chronic respiratory diseases, including asthma. Therapies focusing on repairing vulnerable airways, particularly in early life, present a potentially novel treatment strategy. We report defective lower airway epithelial cell repair to strongly associate with common pre–school-aged and school-aged wheezing phenotypes, characterized by aberrant migration patterns and reduced integrin α5β1 expression. Next generation sequencing identified the PI3K/Akt pathway as the top upstream transcriptional regulator of integrin α5β1, where Akt activation enhanced repair and integrin α5β1 expression in primary cultures from children with wheeze. Conversely, inhibition of PI3K/Akt signaling in primary cultures from children without wheeze reduced α5β1 expression and attenuated repair. Importantly, the FDA-approved drug celecoxib — and its non–COX2-inhibiting analogue, dimethyl-celecoxib — stimulated the PI3K/Akt–integrin α5β1 axis and restored airway epithelial repair in cells from children with wheeze. When compared with published clinical data sets, the identified transcriptomic signature was also associated with viral-induced wheeze exacerbations highlighting the clinical potential of such therapy. Collectively, these results identify airway epithelial restitution via targeting the PI3K–integrin α5β1 axis as a potentially novel therapeutic avenue for childhood wheeze and asthma. We propose that the next step in the therapeutic development process should be a proof-of-concept clinical trial, since relevant animal models to test the crucial underlying premise are unavailable.Keywords
Funding Information
- National Health and Medical Research Council (1048910)
- The University of Western Australia (Australian Postgraduate Award)
- Centre for Cell Therapy and Regenerative Medicine (PhD Top-Up scholarship)
- Asthma Foundation of Western Australia (PhD Top-Up Scholarship)
- National Health and Medical Research Council (Practitioner Fellowship)
This publication has 59 references indexed in Scilit:
- ‘See-saw’ expression of microRNA-198 and FSTL1 from a single transcript in wound healingNature, 2013
- InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curationNucleic Acids Research, 2012
- Recurrent severe exacerbations in early life and reduced lung function at school ageJournal of Allergy and Clinical Immunology, 2012
- ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial CellsThe American Journal of Pathology, 2012
- Development of the bronchial epithelial reticular basement membrane: relationship to epithelial height and ageThorax, 2011
- Decreased Fibronectin Production Significantly Contributes to Dysregulated Repair of Asthmatic EpitheliumAmerican Journal of Respiratory and Critical Care Medicine, 2010
- A new look at the pathogenesis of asthmaClinical Science, 2009
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- Ultrastructure of the reticular basement membrane in asthmatic adults, children and infantsEuropean Respiratory Journal, 2006